Bharat Parenterals Limited — Erythromycin Exporter Profile
Indian Pharmaceutical Exporter · #7 for Erythromycin · $1.4M export value · DGFT Verified
Bharat Parenterals Limited is the #7 Indian exporter of Erythromycin with $1.4M in export value and 37 verified shipments. Bharat Parenterals Limited holds a 1.7% market share in Erythromycin exports across 2 countries. The company exports 10 pharmaceutical products worth $5.2M across 8 therapeutic categories.
Bharat Parenterals Limited — Erythromycin Export Profile: Buyers & Destinations
Where Does Bharat Parenterals Limited Export Erythromycin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| MOZAMBIQUE | $1.1M | 34 | 88.1% |
| GUINEA | $147.3K | 3 | 11.9% |
Bharat Parenterals Limited exports Erythromycin to 2 countries. The largest destination is MOZAMBIQUE accounting for 88.1% of Bharat Parenterals Limited's Erythromycin shipments. These destinations reflect Bharat Parenterals Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Erythromycin from Bharat Parenterals Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| AFRI FARMACIA LDA, | MOZAMBIQUE | $271.1K | 7 |
| MISAU-CENTRAL DE MEDICAMENTOS E | MOZAMBIQUE | $201.5K | 6 |
| MISAU-CENTRAL DE MEDICAMENTOS | MOZAMBIQUE | $173.2K | 4 |
| PHARMACIE CENTRALE DE GUINEE, | GUINEA | $147.3K | 3 |
| MINISTRIO DA SADE CENTRAL DE | MOZAMBIQUE | $144.4K | 5 |
| MINISTERIO DA SAUDE CENTRAL DE | MOZAMBIQUE | $139.6K | 4 |
| MINISTERIO DA SAUDE CENTRAL DE MEDICAMENTOS E ARTIGOS | MOZAMBIQUE | $69.6K | 2 |
| MINISTERIO DA SAUDE CENTRAL DE MED | MOZAMBIQUE | $55.5K | 2 |
| MISAU CENTRAL DE MEDICAMENTOS E | MOZAMBIQUE | $33.0K | 1 |
| MISAU-CENTRAL DE | MOZAMBIQUE | $7.0K | 1 |
Bharat Parenterals Limited supplies Erythromycin to 11 buyers globally. The largest buyer is AFRI FARMACIA LDA, (MOZAMBIQUE), followed by MISAU-CENTRAL DE MEDICAMENTOS E (MOZAMBIQUE) and MISAU-CENTRAL DE MEDICAMENTOS (MOZAMBIQUE). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Erythromycin Export Value and How Much Does Bharat Parenterals Limited Contribute?
India exported $19.0M worth of Erythromycin through 3,939 shipments from 368 suppliers to 135 countries, serving 992 buyers globally. Bharat Parenterals Limited contributes $1.4M to this total, accounting for 1.7% of India's Erythromycin exports. Bharat Parenterals Limited ships Erythromycin to 2 countries through 11 buyers.
What Is the Average Shipment Value for Bharat Parenterals Limited's Erythromycin Exports?
Bharat Parenterals Limited's average Erythromycin shipment value is $36.6K per consignment, based on 37 shipments totaling $1.4M. The largest destination is MOZAMBIQUE (88.1% of Bharat Parenterals Limited's Erythromycin exports).
How Does Bharat Parenterals Limited Compare to Other Indian Erythromycin Exporters?
Bharat Parenterals Limited ranks #7 among 368 Indian Erythromycin exporters with a 1.7% market share. The top 3 exporters are MEDOPHARM ($3.0M), S KANT HEALTHCARE LIMITED ($2.8M), MEDREICH LIMITED ($2.1M). Bharat Parenterals Limited processed 37 shipments to 2 destination countries.
What Erythromycin Formulations Does Bharat Parenterals Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| ERYTHROMYCIN STEARATE TABLET 500MG (EACH FILM COATED TABLETS CONTAINS ERYTHROMYCIN STEARATE EQUIVALENT TO 500MG OF ERYTH | $284.5K | 8 |
| Erythromycin Stearate Tablets BP 500mg U | $271.1K | 7 |
| ERYTHROMYCIN STEARATE TABLET BP 500MG E | $127.5K | 4 |
| ERYTHROMYCIN STEARATE TABLET BP 500MG (EACH FILM COATED TABLETS CONTAINS ERYTHROMYCIN STEARATE EQUIVALENT TO BP 500MG OF | $106.9K | 3 |
| ERYTHROMYCIN STEARATE TABLET BP 500MG (E | $105.1K | 4 |
| ERYTHROMYCIN STEARATE TABLET 500MG (EACH FILM COATED TABLETS CONTAINS ERYTHROMYCIN STEARATE EQUIVALENT TO 500MG OF ERYT | $97.2K | 3 |
| ERYTHROMYCIN STEARATE TABLET BP 500MG EACH FILM COATED TABLETS CONTAINS ERYTHROMYCIN STEARATE EQUIVALENT TO BP 500MG OF | $69.6K | 2 |
| Erythromycin Stearate Tablet BP 500mg. ( | $50.0K | 1 |
| Erythromycin Stearate Tablet BP 500mg (E | $50.0K | 1 |
| Erythromycin Stearate Tablet BP 500mg.( | $47.3K | 1 |
Bharat Parenterals Limited exports 13 distinct Erythromycin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ERYTHROMYCIN STEARATE TABLET 500MG (EACH FILM COATED TABLETS with 8 shipments worth $284.5K.
How Does Bharat Parenterals Limited Compare to Nearest Erythromycin Exporters?
Exporters ranked immediately above and below #7 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 5 | MEDREICH LIMITED | $2.1M | 96 | 4 | $22.1K |
| 6 | CADILA PHARMACEUTICALS LIMITED | $1.4M | 69 | 5 | $20.8K |
| 7 | BHARAT PARENTERALS LIMITED ★ | $1.4M | 37 | 2 | $36.6K |
| 9 | BIOMATRIX HEALTHCARE PRIVATE LIMITED | $1.3M | 46 | 4 | $28.0K |
| 10 | ANGEL BIOGENICS PRIVATE LIMITED | $1.2M | 28 | 2 | $44.6K |
Bharat Parenterals Limited ranks #7 among 368 Indian Erythromycin exporters. Average shipment value of $36.6K compared to the market average of $51.7K. The closest competitors by value are MEDREICH LIMITED and CADILA PHARMACEUTICALS LIMITED.
Which Indian Ports Ship Erythromycin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 513 | 13.0% |
| DELHI AIR CARGO ACC (INDEL4) | 394 | 10.0% |
| SAHAR AIR | 377 | 9.6% |
| NHAVA SHEVA SEA (INNSA1) | 370 | 9.4% |
| JNPT/ NHAVA SHEVA SEA | 234 | 5.9% |
| DELHI AIR | 227 | 5.8% |
| JNPT | 176 | 4.5% |
| Bombay Air | 99 | 2.5% |
About Bharat Parenterals Limited
Bharat Parenterals Limited exports 10 products worth $5.2M. Beyond Erythromycin, top products include Dolutegravir, Tenofovir, Acetylsalicylic, Salicylic, Lactulose. View the complete Bharat Parenterals Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Erythromycin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Erythromycin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Bharat Parenterals Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 37 individual customs records matching Bharat Parenterals Limited exporting Erythromycin, covering 13 formulations to 2 countries via 11 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 135+ countries, 992+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Erythromycin Export Data from Bharat Parenterals Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Bharat Parenterals Limited's Erythromycin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Bharat Parenterals Limited
Full Company Profile →
10 products · $5.2M total trade · 8 categories
Erythromycin Stats
Company Overview
Top Products by Bharat Parenterals Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Bharat Parenterals Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Erythromycin. For current shipment-level data, contact TransData Nexus.